Ellevest, Inc. Curis Inc Transaction History

Ellevest, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	BUY	$0.71 - $2.43 $117 - $400	165 Added 196.43%	249 $0
Q1 2022 Apr 19, 2022	BUY	$2.31 - $5.13 $94 - $210	41 Added 95.35%	84 $0
Q4 2021 Jan 24, 2022	BUY	$4.45 - $8.09 $191 - $347	43 New	43 $0

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.